Advanced search
Publication Cover
mAbs Volume 13, 2021 - Issue 1
Submit an article Journal homepage
9,203
Views
3
CrossRef citations to date
0
Altmetric
Report

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors

Adam R. Roota BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Gurkan Guntasa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Madan Katragaddaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
James R. Apgara BioMedicine Design, Pfizer Inc., Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0002-4669-0188View further author information
ORCID Icon,
Jatin Narulaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Chew Shun Changa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Sara Hanscoma BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Matthew McKennaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Jason Wadea BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Caryl Meadea BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Weijun Maa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Yongjing Guoa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Yan Liua BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Weili Duana BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Claire Hendershota BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Amy C. Kinga BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Yan Zhanga BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Eric Sousaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Amy Tama BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Susan Benarda BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Han Yanga BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Kerry Kellehera BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Fang Jina BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Nicole Piche-Nicholasa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0003-0695-7965View further author information
ORCID Icon,
Sinead E. Keatingb BioMedicine Design, Pfizer Inc., Dublin, IE, USAView further author information
,
Fernando Narciandib BioMedicine Design, Pfizer Inc., Dublin, IE, USAView further author information
,
Rosemary Lawrence-Hendersonc BioMedicine Design, Pfizer Inc., Andover, MA, USAView further author information
,
Maya Araia BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Wayne R. Stochaja BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Kristine Svensona BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Lidia Mosyaka BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Khetemcnee Lamc BioMedicine Design, Pfizer Inc., Andover, MA, USAView further author information
,
Christopher Francisc BioMedicine Design, Pfizer Inc., Andover, MA, USAView further author information
,
Kimberly Marquettea BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Liliana Wroblewskaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
H. Lily Zhuc BioMedicine Design, Pfizer Inc., Andover, MA, USAView further author information
,
Alfredo Darmanin Sheehanb BioMedicine Design, Pfizer Inc., Dublin, IE, USAView further author information
,
Edward R. LaValliea BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Aaron M. D’Antonaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Alison Bettsa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Lindsay Kingc BioMedicine Design, Pfizer Inc., Andover, MA, USAView further author information
,
Edward Rosfjordd Oncology Research & Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Orla Cunninghamb BioMedicine Design, Pfizer Inc., Dublin, IE, USAORCID Iconhttps://orcid.org/0000-0002-3888-9541View further author information
ORCID Icon,
Laura Lina BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Puja Saprad Oncology Research & Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Lioudmila Tchistiakovaa BioMedicine Design, Pfizer Inc., Cambridge, MA, USAView further author information
,
Divya Mathurd Oncology Research & Development, Pfizer Inc., Pearl River, NY, USAView further author information
&
Laird Blooma BioMedicine Design, Pfizer Inc., Cambridge, MA, USACorrespondence[email protected]
View further author information
 show all
Article: 1850395 | Received 13 Jul 2020, Accepted 10 Nov 2020, Published online: 18 Jan 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.